Tag: marijuana legalization

Marijuana Rescheduling Blocked By Opposition ‘From Within’ DEA, Biden’s Drug Czar Says

Former President Joe Biden’s drug czar says the process to reschedule marijuana as initiated under the last administration may have been compromised by officials with the Drug Enforcement Administration (DEA), which was supposed to be defending the proposed policy change.

At the same time, a pro-legalization former  OP congressman allied with President Donald Trump is raising questions about the sincerity of the current president’s endorsement of rescheduling on the campaign trail.

About four months into Trump’s second term, there has still been no movement on the pending plan to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), leaving advocates and stakeholders frustrated both by the current inaction but also the Biden administration’s failure to get the job done before the transition.

According to former White House Office of National Drug Control Policy (ONDCP) Director Rahul Gupta, that may have been due to deliberate resistance from within DEA—a suspicion shared widely among supporters of the reform, including those involved in an administrative hearing that’s been stalled for months, with no clear indication it will proceed any time soon.

“We got stuck moving at the slow speed of government, which was also marred, potentially, by some opposing it from within,” Gupta told The New York Times as part of a broader story examining the rescheduling effort.

The article also features interviews with a former senior DEA agent and former Rep. Matt Gaetz (R-FL), who notably suggested that Trump’s endorsement of a Schedule III reclassification on the campaign trail was essentially an attempt to shore up support among young voters rather than a sincere reflection of his personal views about cannabis.

As far as speculation about DEA’s role in the protracted process goes, there are several factors that have led many to conclude the agency’s leadership internally opposed the proposal, including the fact that there was a break in precedent when then-Attorney General Merrick Garland signed off on it after the U.S. Department of Health and Human Services (HHS) made the recommendation. Historically, the DEA administrator approves drug scheduling proposals.

Keep reading

DEA Blames Legal Marijuana States For Inadvertently Aiding Cartels While Also Admitting That Prohibition States Create Illegal Market Opportunities

The Drug Enforcement Administration (DEA) says that states that have legalized marijuana are providing cover for illicit cultivation operations by foreign cartels—while at the same time implicitly acknowledging that ongoing prohibition in other states creates opportunities for that cannabis to be sold on the illegal market.

The agency’s 2025 National Drug Threat Assessment that was released on Thursday includes a section on marijuana trafficking, claiming that cartels and other organized crime groups “operate under business registrations granted by state licensing authorities in jurisdictions where marijuana cultivation and sales are ‘legal’ at the state level.”

“However, absent overt evidence such as the trafficking of marijuana across state lines or the commission of non-drug crimes such as money laundering and human trafficking, it can be difficult for law enforcement to immediately identify violations or discover an illegal grow,” the report says. “Asian [Transnational Criminal Organizations, or TSOs] defy restrictions on plant quantities, production quotas, and non-licensed sales, and hide behind state-by-state variations in laws governing plant counts, registration requirements, and accountability practices.”

DEA suggested that cartels are leveraging state cannabis markets by transporting “large amounts of marijuana directly from ‘legal’ states to states that have not legalized recreational use and those where state-level recreational approval is sufficiently recent to not yet have an established, regulated cannabis industry.”

Underlying that analysis seems to be a perhaps inadvertent acknowledgment by DEA that cartels are profiting off ongoing prohibition outside of legal states—indicating that the main demand for illicit marijuana isn’t coming from within states that provide regulated access to consumers but instead those where cannabis remains criminalized.

Implicit in that analysis is exactly what advocates have long argued: Legalization disrupts the illegal market.

Keep reading

Members Of Congress Want Federal Investigation Into Use Of Florida Medicaid Funds To Oppose Marijuana Legalization By Group Tied To DeSantis

Two Democratic members of Congress representing Florida are asking the federal government to investigate what they describe as “potentially unlawful diversion” of millions in state Medicaid funds via a group with ties to Gov. Ron DeSantis (R). The money was used to fight against a citizen ballot initiative, vehemently opposed by DeSantis, that would have legalized marijuana for adults.

Reps. Kathy Castor and Darren Soto sent a letter on Thursday to the Department of Health and Human Services (HHS) inspector general as well as Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services, formally requesting they initiate a Medicaid fraud investigation.

“The diversion of Medicaid dollars requires immediate investigation,” the two lawmakers wrote. “These are proceeds that rightfully belong to state taxpayers to serve the citizens who rely on Medicaid, including children, pregnant women, neighbors with disabilities and those served by long-term care.”

The two lawmakers, members of a House committee with oversight of Medicaid, emphasized that Congress is “very focused on waste, fraud and abuse of Medicaid dollars.”

“Any unlawful diversion of Medicaid dollars in Florida,” they wrote, “means that the state is less able to provide services to our neighbors who rely on Medicaid and the providers who serve them.”

The letter follows allegations that a $10 million donation from a state legal settlement was improperly made to the Hope Florida Foundation, which later sent the money to two political nonprofits, which in turn sent $8.5 million to a campaign opposing the proposed marijuana legalization ballot measure, Amendment 3.

Notably, the Hope Florida Foundation was founded by Florida First Lady Casey DeSantis, the governor’s wife.

“On October 17, Secure Florida’s Future donated $2 million to Keep Florida Clean Inc., a Political Action Committee (PAC) controlled by Governor DeSantis’s then-chief of staff James Uthmeier that was created to campaign against Amendment 3,” the lawmakers’ new letter says. “Governor DeSantis strongly opposed Amendment 3. Days later, Secure Florida’s Future sent Keep Florida Clean Inc. an additional $1.75 million.”

“On October 22, the Hope Florida Foundation wired $5 million to the 501(c)4 nonprofit Save Our Society from Drugs that proposed spending the ‘grant’ on ‘developing and implementing strategies that directly address the substance use crisis facing our communities,’” it continues, detailing the alleged impropriety. “On October 23, the next day, Save Our Society from Drugs donated $1.6 million to Keep Florida Clean Inc. Over the coming days, Save Our Society from Drugs donated an additional $3.15 million to Keep Florida Clean Inc.”

“While there are limited financial disclosure requirements associated with 501(c)4 organizations,” the lawmakers said, “records appear to show that a total of $8.5 million from the Centene settlement with AHCA went from the Hope Florida Foundation to the Amendment 3-focused Keep Florida Clean, Inc. PAC, the same PAC that also donated funding to the Republican Party of Florida and the Florida Freedom Fund. ”

“Hope Florida had raised only about $2 million during its three years of existence,” they pointed out, “but in one fell swoop, received $10 million from a Medicaid settlement, which was immediately funneled through other nonprofits to a PAC directed by the Governor’s Chief of Staff.”

Keep reading

GOP-Led Wisconsin Committee Cuts Governor’s Marijuana Legalization Proposal From Budget

Republicans in Wisconsin’s legislature on Thursday cut key provisions from a state budget proposal by Gov. Tony Evers (D), including plans to legalize and regulate marijuana.

The changes came in a Joint Finance Committee hearing, where members removed a long list of items included in the governor’s budget. In addition to cannabis legalization, other deleted items include tax cuts for the middle class, tax increases for millionaires and state support for children, farmers and veterans.

Evers said on social media ahead of the vote that “today, Republican lawmakers are gutting my budget that does what’s best for our kids and the folks, families, and communities that raise them.”

The committee’s 21 pages of cuts remove multiple marijuana provisions from Evers’s budget, such as regulation, taxation, licensing and civil and criminal legal adjustments.

The actions are a repeat of two years ago, when GOP members of the same committee removed proposals to legalize marijuana for recreational and medical use from the governor’s biennial executive budget at that time.

A press release from the governor’s office about Thursday’s committee changes says the legalization proposal would have regulated marijuana “much like the state already does with alcohol, which would help Wisconsin compete with other states for talented workers and have more resources to invest in critical state priorities.”

The reform is “a proposal that over 60 percent of Wisconsinites support,” the release notes, pointing to a poll from February.

Keep reading

Pennsylvania House Approves Bill To Legalize Marijuana Sales Through State-Owned Stores

The Pennsylvania House of Representatives has given initial approval to a bill that would legalize marijuana with a novel model of state-run stores.

This has been an especially fast-moving legislative process for the measure from Reps. Rick Krajewski (D) and Dan Frankel (D). It was introduced on Sunday, advanced through the House Health Committee Frankel chairs on Monday and has now been approved on second reading in the full chamber on Tuesday in a vote of 102-101.

All Democrats in the body voted in favor of the legislation, and all Republicans were opposed. A third reading vote, expected soon, would send the measure to the Senate.

While there’s a competing bipartisan legalization measure that’s expected to be unveiled soon, this one already has 27 House Democrats signed on as cosponsors—more than one-fourth of the party’s caucus in the chamber.

The expedited consideration of the bill has already elicited criticism from the GOP side of the aisle, with Rep. Charity Grimm Krupa (R), a member of the Health Committee, saying during Monday’s Health Committee hearing that “it’s no secret that I stand in opposition to broadly legalized adult-use marijuana—but frankly, I’m appalled by the manner in which it’s being rammed through the committee and the legislature.”

Frankel responded to the critique, saying “this has been a transparent process” that has “taken into consideration input from every potential stakeholder.”

“My door has been open to all those stakeholders on an ongoing basis for the past two year—the six hearings we had and an opportunity for the minority party to have to have a meeting to talk about this,” the chair said.

Keep reading

With Florida Marijuana Legalization Measure Circulating, DeSantis Signs Bill Making It Harder To Qualify Ballot Initiatives

Fresh changes to Florida law on ballot initiatives will create new hurdles for advocates aiming to put legislative proposals before voters—including, potentially, the renewed effort to legalize marijuana in the state.

Florida Gov. Ron DeSantis (R) on Friday signed a measure into law that tightens requirements around citizen-initiated measures. Among other requirements, it mandates that supporters post a $1 million bond before commencing signature gathering, prohibits the use of out-of-state and noncitizen petitioners and narrows the window during which which signatures must be submitted to election officials.

The bill’s sponsor, Rep. Jenna Persons-Mulicka (R), contends the ballot initiative process “has been taken over by out of state fraudsters looking to make a quick buck and by special interests intent on buying their way into our Constitution.”

“The bill seeks to root out the problem and provide assurances that only those with a stake in our Constitution can change it to that end,” she said at a hearing in March.

DeSantis, for his part, said on social media over the weekend that the bill will “combat petition fraud and prevent the special interest-abuse of our constitutional amendment process.”

Changes under the new law will also prevent Floridians with felony convictions from collecting petition signatures unless they’ve gone through the process of restoring their voting rights.

Residents will also have to provide personal details—including their driver’s license number, voter ID card number or the last four digits of their Social Security number—in order to fill out a petition. The form itself will then become a public record, raising potential privacy concerns.

Campaigns also have less time to return petitions to election officials, and they’ll face harsher fines for errors.

The new obstacles to placing a proposal on the statewide ballot come on the heels of two contentious constitutional amendments that went before voters last year, including one—Amendment 3—that would have legalized marijuana for adults 21 and older, and another on abortion rights.

Keep reading

Pennsylvania Lawmakers Will Vote On Bill To Legalize Marijuana Sales Through A System Of State-Run Stores Today

Pennsylvania Democrats have officially released a much-anticipated bill to legalize marijuana with a novel state-run regulatory model. And it’s already slated for an imminent House committee vote.

The new legislation is being sponsored by Reps. Rick Krajewski (D) and Dan Frankel (D), who chairs the House Health Committee that will be taking up the proposal on Monday.

“The time is now for Pennsylvania,” Krajewski said in a press release. “We have listened carefully to public health experts, criminal justice reformers, small business advocates and community leaders. Our bill reflects what we’ve learned—that we can and must legalize cannabis in a way that is safe, equitable and beneficial to all Pennsylvanians.”

Under the bill, adults 21 and older would be able to legally possess and buy cannabis from stores licensed and operated by the Liquor Control Board (LCB), which currently controls alcohol sales in the state.

While there’s a competing bipartisan legalization measure that’s expected to be unveiled soon, this one already has 27 House Democrats signed on as cosponsors—more than one-fourth of the party’s caucus in the chamber.

“By legalizing and regulating cannabis thoughtfully, we can avoid pitfalls that have marred roll outs in other states,” Frankel said. “Our plan will create clear rules that protect consumers, educate the public, and ensure that Pennsylvania small businesses and taxpayers—not out-of-state corporations—benefit from the profits.”

LCB would directly control the cannabis retail side of the industry under the measure, but it would also be responsible for licensing marijuana cultivation, processing, transportation and on-site consumption businesses that could be privately owned.

The legislation would specify that cannabis shops could not sell more than 42.5 grams of marijuana, which would be the possession limit, to an adult within a 24-hour period. Cannabis flower could not contain more than 25 percent THC, and edibles would be limited to five milligrams of THC per serving, with a maximum 25 milligrams total.

Adults who obtain a home cultivation permit from LCB would be able to grow up to two mature and two immature plants in a secure location at their residence for personal use.

Marijuana products sold at licensed shops would be subject to a 12 percent excise tax. Revenue from those taxes would be deposited in a Cannabis Revenue Fund, managed by the Department of Revenue (DOR).

That fund would be used to cover administrative costs within the various departments that have a hand in regulating the cannabis program, including the facilitation of expungements for people with prior marijuana convictions for activity that would be made legal under the law.

The remaining revenue would be distributed for a community reinvestment fund (50 percent), substance misuse treatment programs (10 percent), cannabis business development (5 percent), minority business development (2.5 percent) and grants to county courts that process expungements (2 percent).The rest would go into the state general fund.

The Administrative Office of Pennsylvania Courts would be tasked with overseeing cannabis expungements, providing courts with a list of eligible cases that must be automatically sealed within two years.

A Social and Economic Equity Advisory Committee would be established under the bill to “promote inclusion and participation in the regulated cannabis industry, including through an indirect cannabis business, by persons that may qualify to be a social and economic equity applicant.”

The committee would be responsible for a new Social and Economic Equity Loan and Grant Program that would “provide financial assistance to certified social and economic equity applicants, certified social and economic equity licensees and indirect cannabis businesses that meet the qualifications of a social and economic equity applicant.”

Eligible social and economic equity applicants are defined as those with a “household annual income below 200 percent of the Area Median Income in their county of residence,” and they’d also have to either have a minimum of 65 percent ownership by justice-impacted individuals or those who’ve spent five of the last 10 years in a designated historically impacted community.

The bill also contains rules around policies related to cannabis advertising, packaging and labeling—as well as requirements for businesses around ownership and a mandate to have a labor peace agreement in place for workers.

The largest challenge for the legislation going forward will likely come down to the proposal to have the state control cannabis sales—a regulatory model that exists in no other legal market in the U.S. While there’s evidently strong support within the Democratic caucus given the cosponsorship list, it’s expected to face steep resistance from Republicans, who control the Senate, and at least some Democrats.

For what it’s worth, a recent poll found that Pennsylvania voters say they favor a model where cannabis is sold by licensed private businesses, rather than through a system of state-run stores.

Keep reading

Pennsylvania Lawmakers Approve Bill To Legalize Marijuana Just One Day After It Was Introduced

Just one day after Pennsylvania Democrats filed a much-anticipated bill to legalize marijuana with a novel model of state-run stores, a House committee has already approved the measure—with floor consideration now expected imminently in the face of criticism about how fast the proposal is advancing.

The legislation is being sponsored by Reps. Rick Krajewski (D) and Dan Frankel (D), who chairs the House Health Committee that took up the proposal on Monday, where it passed in a party-line vote of 14-12 with all Republican members in opposition.

The measure now moves to the House floor, where an initial vote is expected as soon as Tuesday.

“Right now, Pennsylvanians who use cannabis are either crossing state lines to purchase from other legal markets or buying from the illicit market,” Krajewski said at the hearing. “The reality is criminalization of cannabis does not work. It does not deter usage, it does not promote safety and it is not in the best interest of our commonwealth.”

“With legalization, we have the opportunity to rein in a market that is completely deregulated in terms of potency, content or labeling,” he said. “We can promote public health while bringing hundreds of millions of public dollars that can be directed to the communities hit hardest by past criminalization.”

Keep reading

Louisiana Lawmaker Proposes Marijuana Legalization Pilot Program As ‘Revenue Source’ For The State

Louisiana lawmakers are gearing up for another push to legalize marijuana in the state, with at least two proposals now filed to enact cannabis-related reform this session.

Rep. Candace Newell (D)—who has made repeated attempts to end criminalization—discussed her latest legislation in an interview with Louisiana First News that aired on Saturday, describing a proposed three-year pilot program that is “designed to test and evaluate parameters of the implementation of a permanent adult-use cannabis program,” according to a legislative analysis.

“Aside of just wanting to have legalized recreational marijuana, I’m also looking at another revenue source in the state of Louisiana,” Newell said. “I’m talking about statewide, across the board, education on the product—the use of the product, the dangers of it and how it can be beneficial.”

The sponsor added that, from her perspective, “what we’ve seen is the states where they’ve done just the full blanket legalization and regulation that that is failing.”

At the same time, she emphasized the potential revenue stream from legalizing and taxing cannabis for adults.

Keep reading

White House Drug Czar Could Endorse Marijuana Legalization Under New Bill To Repeal ‘Ludicrous’ Restriction

Democratic congressional lawmakers have announced the filing of a bill that would remove a restriction that’s prevented the White House drug czar from advocating for the legalization of marijuana or other Schedule I drugs under the Controlled Substances Act (CSA).

At a Last Prisoner Project (LPP) event outside the Capitol on Tuesday, Reps. Dina Titus (D-NV) and Ilhan Omar (D-MN)—co-chairs of the Congressional Cannabis Caucus—talked about the group’s legislative priorities for marijuana reform. Beyond the new bill, that will also include bipartisan legislation to end federal prohibition in legal states and free up the industry to access banking services.

The lawmakers’ “Evidence-Based Drug Policy Act” would take aim at a federal statute prohibiting the director of the White House Office of National Drug Control Policy (ONDCP) from promoting reform around Schedule I drugs.

The current law states that no funds provided to ONDCP can be used for “any study or contract relating to the legalization (for a medical use or any other use) of a substance listed in schedule I,” further requiring the office’s director to “take such actions as necessary to oppose any attempt to legalize the use of a substance (in any form)” that is in Schedule I and has not been approved for use for medical purposes by the Food and Drug Administration (FDA).

Under the two-page bill, that statutory language included in section 704(b)(12) of the ONDCP Reauthorization Act would be repealed.

Titus said on Tuesday that the legislation would “remove outdated restrictions, which are just ludicrous.”

“They’re not allowed to sponsor any research on Schedule I drugs. They can’t even talk about it, to show you how ridiculous is,” she said. “And by law, they have to actively oppose the legalization of any substance that is Schedule I and not approved by the FDA. We’re trying to remove that prohibition.”

Marijuana legalization “is not some out-of-nowhere kind of issue. This is something that is truly mainstream,” Titus said. “So if we can get rid of that policy, we can begin to do research on some of the advantages, or how marijuana can be used and what are the medical implications so when they say, ‘Oh, we don’t know—we don’t know what it’ll do, it might be dangerous’—you can counter that with good research.”

Whether the Trump administration’s recently appointed drug czar would exercise the authority to advocate for reform under the bill if enacted is uncertain. However, ONDCP Director Sara Carter has previously called medical marijuana a “fantastic” treatment option for seriously ill patients and said she doesn’t have a “problem” with legalization, even if she might not personally agree with the policy.

Keep reading